ARCHIVES

Review Group Report: NCI Role In Drug Development Seen As Information Provider

This article is from The Cancer Letter archive.

Vol. 24 No. 42 | November 6, 1998

Download PDF Visit The Full Archive

Related Articles

Study Suggests Biomarker For Resistance to Tamoxifen

March 25, 2011

Bast Named VP For Translational Research And Co-PI Of Core Grant At M. D. Anderson.

March 24, 2000

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

September 6, 2002

NCI to Close Clinical Branch at Frederick, Move Patients, Protocols To Bethesda

May 17, 1996

Foreign awards Less Than 1% Of NCI Budget

June 22, 1990

DCT Board to Study Modifications Of Existing Cooperative Group System

June 13, 1986